This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Pfizer Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Paul Robert Mehelic
Introduction
Paul Robert Mehelic is an accomplished inventor based in St. Charles, MO (US). He has made significant contributions to the field of medical science, particularly in the area of nicotine addiction. His work has the potential to impact many lives by providing new avenues for treatment and prevention.
Latest Patents
Mehelic holds a patent for "Conjugates for the prevention or treatment of nicotine addiction." This invention relates to nicotine-derived hapten-carrier conjugates, which can be utilized to prepare vaccines aimed at treating and preventing nicotine addiction. The formula and specific components of these conjugates are detailed in the patent description.
Career Highlights
Paul Robert Mehelic is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other talented professionals in the field, contributing to innovative solutions for health-related challenges.
Collaborations
Some of his notable coworkers include Alan Daniel Brown and Heather Lynn Davis. Their collective expertise enhances the research and development efforts at Pfizer, fostering an environment of innovation.
Conclusion
Paul Robert Mehelic's work exemplifies the spirit of innovation in the medical field. His contributions to nicotine addiction treatment highlight the importance of research and collaboration in developing effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile